Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 11 April 2018

Indication(s)

Zerbaxa is indicated for the treatment of the following infections in adults:
- Complicated intra-abdominal infections;
- Acute pyelonephritis;
- Complicated urinary tract infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hyperammonaemia

Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

+ 2 more

Breakthrough Cancer Pain Learning Zone

Breakthrough Cancer Pain Learning Zone

Watch video highlights from the BeCOn OWN 2017 event, including expert opinion, patient experience and panel discussions in the Breakthrough Cancer Pain Learning Zone.

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/003772
Orphan designation No
Date First Approved 18-09-2015
Type Medicinal product subject to medical prescription
Marketing authorisation holder Merck Sharp & Dohme Limited
Warnings This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions